Tracking Balance and Walking Recovery After Stroke
FOSTER
Mapping the Time Course of Recovery of Sitting and Standing Balance and Walking After Stroke
1 other identifier
observational
100
1 country
1
Brief Summary
This study aims to understand how balance and walking abilities recover after a stroke, using innovative tools like an interactive assessment game. By observing patients over time, the investigators seek to identify recovery patterns that can improve rehabilitation strategies tailored to individual needs. Interacting with a game designed to assess balance and movement, participants will perform tasks involving sitting balance, standing balance, and gait initiation. The game measures aspects like reaction time, movement accuracy, and postural control, providing detailed insights into recovery progress. These data will validate prediction models to support personalized care. The study is non-invasive, does not interfere with usual care, and prioritizes patient safety. The investigators' ultimate goal is to enhance the understanding of recovery, leading to better care and improved quality of life for stroke survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2024
CompletedStudy Start
First participant enrolled
January 7, 2025
CompletedFirst Posted
Study publicly available on registry
February 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 9, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 9, 2028
July 16, 2026
July 1, 2026
3.9 years
November 29, 2024
July 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Postural control
Postural control during dynamic tasks (sitting, standing, gait initiation) measured using wearable sensors (e.g., IMUs) and other biomechanical measurement systems (e.g., force plates, Kinect cameras).
Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Weight distribution
Weight distribution during balance and movement tasks (standing, gait initiation) using force plates.
Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Movement coordination
Movement coordination assessed during functional motor tasks (sitting, standing, gait initiation) using wearable sensors (e.g., IMUs), force plates, and Kinect camera.
Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Neuromuscular activity
Neuromuscular activity evaluated during dynamic tasks (sitting, standing, gait initiation) using muscle activity measurement systems (e.g., EMG sensors).
Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Secondary Outcomes (15)
Reaction time
Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Movement time
Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Reaching or stepping accuracy
Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Upper limb dynamics
Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Daily activity monitoring
Baseline, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
- +10 more secondary outcomes
Study Arms (1)
Patients in the first 6 months after stroke
Participants will be adults aged 18 years or older who have experienced a supratentorial ischaemic or haemorrhagic stroke and are within eight weeks after stroke onset at inclusion. Inclusion will occur as soon as feasible after admission to the rehabilitation hospital. Participants must be able to understand and perform the study procedures feasible at each assessment, based on the advice of the treating therapist(s) and/or physician(s). Written informed consent will be obtained from the participant or, where applicable, a legally authorised representative. Exclusion criteria are neurological or orthopaedic comorbidities unrelated to stroke that significantly impair motor function, severe medical conditions that could compromise safety, major deficits in communication, memory or understanding that prevent participation, and insufficient comprehension of Dutch, French, German or English. Independent walking, standing balance and ability to perform the exergame tasks are not required.
Interventions
Description: Patients after stroke who meet the eligibility criteria will be assessed three to five times during the first six months after stroke, depending on the timing of inclusion.
Eligibility Criteria
Patients in the first 6 months after stroke: Participants will be adults aged 18 years or older who have experienced a supratentorial ischaemic or haemorrhagic stroke and are included within eight weeks after stroke onset. They will be followed during the first six months after stroke.
You may qualify if:
- Adult aged ≥18 years
- Diagnosis of a supratentorial ischaemic or haemorrhagic stroke
- Able to understand and perform the study procedures that are feasible at a given assessment time point, based on the advice of the treating therapist(s) and/or physician(s)
- Written informed consent provided by the participant or, where applicable, by a legally authorised representative
You may not qualify if:
- Neurological or orthopaedic comorbidities unrelated to stroke that significantly impair motor function
- Severe medical conditions that could compromise safety during the assessments
- Major deficits in communication, memory or understanding that prevent participation in the study procedures
- Insufficient comprehension of Dutch, French, German or English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vrije Universiteit Brussellead
- Universitair Ziekenhuis Brusselcollaborator
- Revalidatieziekenhuis InkendaaIcollaborator
Study Sites (1)
Inkendaal rehabilitation hospital
Sint-Pieters-Leeuw, Brussels Capital, 1602, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 24 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 29, 2024
First Posted
February 4, 2025
Study Start
January 7, 2025
Primary Completion (Estimated)
December 9, 2028
Study Completion (Estimated)
December 9, 2028
Last Updated
July 16, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
This study is part of the EU Horizon 2020 TARGET project, following its DMP to ensure data is handled ethically, legally, and sustainably in line with FAIR principles (Findability, Accessibility, Interoperability, Reusability). The plan ensures systematic organization, quality consistency via standardized procedures, and compliance with GDPR, national laws, and EU requirements. Personal data is processed securely, only when necessary for project objectives, with approvals and written consent from participants. Methods include interviews, surveys, workshops, and questionnaires. Data is stored with robust backup and preservation strategies to prevent loss and ensure future usability. Sharing is (currently) restricted to the consortium under a signed data transfer agreement, with external sharing undecided. Data not publicly available includes: third-party data without permission for public release, data compromising IP protection, and participant data that cannot be fully anonymized.